Poly(ADP-ribose) polymerase-1 (PARP-1) and nuclear factor κB (NF-κB) have both been demonstrated to play a pathophysiological role in a number of inflammatory disorders. We recently presented evidence that PARP-1 can act as a promoter-specific coactivator of NF-κB in vivo independent of its enzymatic activity. PARP-1 directly interacts with p300 and both subunits of NF-κB (p65 and p50) and synergistically coactivates NF-κB-dependent transcription. Here we show that PARP-1 is acetylated in vivo at specific lysine residues by p300/CREB-binding protein upon stimulation. Furthermore, acetylation of PARP-1 at these residues is required for the interaction of PARP-1 with p50 and synergistic coactivation of NF-κB by p300 and the Mediator complex in response to inflammatory stimuli. PARP-1 physically interacts with the Mediator. Interestingly, PARP-1 interacts in vivo with histone deacetylases (HDACs) 1-3 but not with HDACs 4-6 and might be deacetylated in vivo by HDACs 1-3. Thus, acetylation of PARP-1 by p300/CREB-binding protein plays an important regulatory role in NF-κB-dependent gene activation by enhancing its functional interaction with p300 and the Mediator complex. © 2005 by The American Societyfor Biochemistry and Molecular Biology, Inc.
CITATION STYLE
Hassa, P. O., Haenni, S. S., Buerki, C., Meier, N. I., Lane, W. S., Owen, H., … Hottiger, M. O. (2005). Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-κB-dependent transcription. Journal of Biological Chemistry, 280(49), 40450–40464. https://doi.org/10.1074/jbc.M507553200
Mendeley helps you to discover research relevant for your work.